EMJ Presents: EMJ Hematology US 2020
The programme was truly magnificent, with >30,000 attendees, >30 special interest and spotlight sessions, 16 scientific programme sessions, and an abundance of oral and poster abstracts available. Our congress review stories, spanning new study outcomes for sickle cell disease patients to socioeconomic factors involved in myeloid leukaemia survival rate, are a taster of these developments. We also include a selection of the presented abstracts as well as interviews with the Chairs of the International Members Committee and Foundation Committee, providing further insights into the congress.
Alongside our congress review we provide a selection of peer-reviewed articles from experts within the field of haematology. The Editor's Pick is a paper by Uwaezouke that discusses current perspectives on the pathogenesis and treatment of acute chest syndrome in children with sickle cell disease. Navada and Belasen present different therapeutic options for patients with myelodysplastic syndromes unresponsive to hypomethylating agents, valuable coverage in that only half of these patients respond to these agents with variable durations of effect. Indulge yourself in these fascinating papers and many more in EMJ Hematology US Edition 1.1.
The full journal is available now at https://www.emjreviews.com/